These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26446586)

  • 1. [Multidrug-resistant bacteria in Germany. The impact of sources outside healthcare facilities].
    Idelevich EA; Lanckohr C; Horn D; Wieler LH; Becker K; Köck R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jan; 59(1):113-23. PubMed ID: 26446586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multidrug-resistant organisms (MDRO) in patients in outpatient care in the Rhine-Main region, Germany, in 2014: Prevalence and risk factors].
    Neumann N; Mischler D; Cuny C; Hogardt M; Kempf VA; Heudorf U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Feb; 59(2):292-300. PubMed ID: 26631014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Healthcare associated infections (HAI), antibiotic use and prevalence of multidrug-resistant bacteria (MDRO) in residents of long-term care facilities: the Frankfurt HALT plus MDRO project 2012].
    Heudorf U; Gustav C; Mischler D; Schulze J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Apr; 57(4):414-22. PubMed ID: 24658671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multidrug-Resistant Organisms (MDRO) in Rehabilitation Clinics in the Rhine-Main District, Germany, 2014: Risk Analysis and Hygiene Procedures].
    Heudorf U; Färber D; Mischler D; Schade M; Zinn C; Nillius D; Herrmann M
    Rehabilitation (Stuttg); 2015 Dec; 54(6):375-81. PubMed ID: 26676735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current prevalence of multidrug-resistant organisms in long-term care facilities in the Rhine-Main district, Germany, 2013.
    Hogardt M; Proba P; Mischler D; Cuny C; Kempf VA; Heudorf U
    Euro Surveill; 2015 Jul; 20(26):. PubMed ID: 26159310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
    Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
    Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care--prevalence and risk factors.
    Gruber I; Heudorf U; Werner G; Pfeifer Y; Imirzalioglu C; Ackermann H; Brandt C; Besier S; Wichelhaus TA
    Int J Med Microbiol; 2013 Dec; 303(8):405-9. PubMed ID: 23770266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Emergence pathogens infections in ENT Department of Children's hospital in 2005-2008].
    Zielnik-Jurkiewicz B; Rakowska-Szkudlarek M
    Otolaryngol Pol; 2009; 63(6):513-9. PubMed ID: 20198987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antimicrobial resistance in Germany : What is the current situation?].
    Maechler F; Geffers C; Schwab F; Peña Diaz LA; Behnke M; Gastmeier P
    Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):186-191. PubMed ID: 28378152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multidrug-Resistant Organisms (MDRO) in Rehabilitation Clinics in the Rhine-Main-District, Germany, 2014: Prevalence and Risk Factors].
    Heudorf U; Färber D; Mischler D; Schade M; Zinn C; Cuny C; Nillius D; Herrmann M
    Rehabilitation (Stuttg); 2015 Oct; 54(5):339-45. PubMed ID: 26505186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection control measures and prevalence of multidrug-resistant organisms in non-hospital care settings in northeastern Germany: results from a one-day point prevalence study.
    Hübner NO; Dittmann K; Begunk R; Kramer A;
    J Hosp Infect; 2017 Nov; 97(3):234-240. PubMed ID: 28797758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current strategies against multi-drug resistant organisms].
    Pletz MW; Eckmann C; Hagel S; Heppner HJ; Huber K; Kämmerer W; Schmitz FJ; Wilke M; Grabein B
    Dtsch Med Wochenschr; 2015 Jun; 140(13):975-81. PubMed ID: 26115132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples.
    Wieler LH; Ewers C; Guenther S; Walther B; Lübke-Becker A
    Int J Med Microbiol; 2011 Dec; 301(8):635-41. PubMed ID: 22000738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of multidrug-resistant organisms in travellers: Results of a 2-year screening in a German level 1 trauma center].
    Seifert J; Frank M; Köln T; Beniers K; Kramer A; Ekkernkamp A; Gümbel D
    Unfallchirurg; 2016 Mar; 119(3):217-24. PubMed ID: 25394753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional trends in multidrug-resistant infections in German intensive care units: a real-time model for epidemiological monitoring and analysis.
    Kohlenberg A; Schwab F; Meyer E; Behnke M; Geffers C; Gastmeier P
    J Hosp Infect; 2009 Nov; 73(3):239-45. PubMed ID: 19804919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nosocomial infections and infections with multidrug-resistant pathogens - frequency and mortality].
    Gastmeier P; Geffers C; Herrmann M; Lemmen S; Salzberger B; Seifert H; Kern W; Fätkenheuer G
    Dtsch Med Wochenschr; 2016 Mar; 141(6):421-6. PubMed ID: 26983115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality attributable to hospital acquired infections with multidrug-resistant bacteria in a large group of German hospitals.
    Neubeiser A; Bonsignore M; Tafelski S; Alefelder C; Schwegmann K; Rüden H; Geffers C; Nachtigall I
    J Infect Public Health; 2020 Feb; 13(2):204-210. PubMed ID: 31420314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of serious nosocomial bacterial infections: do current therapeutic options meet the need?
    Lode H
    Clin Microbiol Infect; 2005 Oct; 11(10):778-87. PubMed ID: 16153251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infections caused by multiresistant bacteria].
    Zahar JR; Ferroni A
    Rev Prat; 2006 Sep; 56(13):1397-404. PubMed ID: 17002063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.